Beike Biotech
China
Shenzhen Beike Biotechnology Co., Ltd.
International Department
9/F, Zhongke Building, No.1 Hi-Tech South Street
South Area, Shenzhen Hi-Tech Industrial Park
Shenzhen, Guangdong Province, China 518057
Tel: +86 0532-6677- 6659
Fax:+86 0532-8577- 9113
About Beike Biotech
Beike Biotechnology is a leading biotechnology company. Since 1999, Beike’s researchers have been focused on the development and commercialization of adult stem cell therapies. The company now produces a full line of stem cell products derived from umbilical cord blood and bone marrow stem cells. Beike's proprietary processing along with its quality assurance technologies prepare the cells to be used to treat a variety of serious medical conditions including ataxia, cerebral palsy, brain injury, diabetic foot disease, lower limb ischemia, muscular dystrophy, multiple sclerosis, spinal cord injury, and optic nerve damage.
Beike's stem cells come from carefully screened healthy donors. The samples are also screened by government appointed blood banks and Beike’s specialized laboratories. The stem cells are banked in state-of-the-art facilities and utilized in partnership with the best hospitals and physicians. The highest quality control procedures are followed at each of Beike’s eighteen laboratories.
Treatment protocols include he injections of umbilical cord blood stem cells, bone marrow mesenchymal stem cells, cord mesenchymal stem cells, and directly into the spinal cord fluid and intravenously. However, for illnesses such as muscular dystrophy, spinal cord injuries, liver disease, heart disease, and lower limb ischemia, the stem cells are delivered through injections directly into the damaged tissue as well as through standard methods. For many illnesses, protocols include rehabilitation and physical therapy.
Print
Email page